搜索结果121-130 的 841 / anti-TNF drugs

  1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... therapy. Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer ...

  2. 帕金森综合征- 症状与病因- 妙佑医疗国际

    帕金森病是一种渐进性疾病，会影响神经系统和受神经控制的身体部位。症状会慢慢出现。初始症状可能是不易察觉的单手震颤。除导致常见的震颤外，这种疾病还可能会导致动作 ...

  3. 神经科- Mayo Clinic 新闻 - 妙佑医疗国际

    六月2024. Clot-busting medication helps retiree return to the open road after a stroke June 28, 2024, 04:00 p.m. CDT · Biology-based criteria for diagnosis, ...

  4. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  5. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  6. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  7. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...

  8. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  9. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...

  10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as well ...